LSIPR and HGF present: Navigating the CRISPR IP landscape in Europe
Dr Claire Irvine (HGF Ltd) Catherine Coombes (HGF Ltd), Peter Scott (Life Sciences IP Review)
About this talk
The CRISPR IP landscape in Europe is very murky. Listeners will gain an understanding of the current situation, which will aid them to make licensing decisions if and when they intend to commercialise. This 45-minute webinar will provide an up to date analysis of the current state of play in Europe with comparison to the state of play in the US.